Preclinical trauma studies of recombinant factor VIIa

Preclinical studies in animals and ex vivo human blood have provided a solid rationale for conducting prospective randomized trials in trauma patients. Small animal models have been utilized to study the efficacy of recombinant activated factor VII (rFVIIa; NovoSeven(®)) in treating thrombocytopenic...

Descripción completa

Detalles Bibliográficos
Autores principales: Schreiber, Martin A, Holcomb, John B, Rojkjaer, Rasmus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3226120/
https://www.ncbi.nlm.nih.gov/pubmed/16221316
http://dx.doi.org/10.1186/cc3782

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3226120/
https://www.ncbi.nlm.nih.gov/pubmed/16221316
http://dx.doi.org/10.1186/cc3782

Ejemplares similares